ロード中...
The Potential of Harnessing IL-2-Mediated Immunosuppression to Prevent Pathogenic B Cell Responses
Immunosuppressive drugs can partially control Antibody (Ab)-dependent pathology. However, these therapeutic regimens must be maintained for the patient’s lifetime, which is often associated with severe side effects. As research advances, our understanding of the cellular and molecular mechanisms und...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8112607/ https://ncbi.nlm.nih.gov/pubmed/33986755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.667342 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|